EP300 and breast cancer: As quercetin exerts a global effect on transactivator binding and p300 recruitment to COX-2 promoter, we determined whether p300 HAT might be a target of transcriptional control by quercetin in human breast cancer cells and evaluated the effect of quercetin on p300 HAT activity in the p300-overexpressed breast cancer cells.